Institutional & Family Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-199
Closed -$3K 770
2022
Q3
$3K Sell
199
-39
-16% -$576 ﹤0.01% 557
2022
Q2
$3K Hold
238
﹤0.01% 565
2022
Q1
$4K Hold
238
﹤0.01% 588
2021
Q4
$3K Sell
238
-2,216
-90% -$31.4K ﹤0.01% 636
2021
Q3
$36K Buy
2,454
+55
+2% +$929 0.01% 375
2021
Q2
$44K Buy
2,399
+2,246
+1,468% +$40K 0.01% 353
2021
Q1
$3K Hold
153
﹤0.01% 766
2020
Q4
$3K Hold
153
﹤0.01% 724
2020
Q3
$2K Hold
153
﹤0.01% 727
2020
Q2
$2K Buy
153
+68
+80% +$894 ﹤0.01% 711
2020
Q1
$1K Hold
85
﹤0.01% 775
2019
Q4
$2K Hold
85
﹤0.01% 758
2019
Q3
$2K Hold
85
﹤0.01% 724
2019
Q2
$2K Buy
+85
New +$1.66K ﹤0.01% 739

Other funds holding SBRA

Institutional & Family Asset Management's SBRA Position: Q4 2022 in Review

Institutional & Family Asset Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2022, closing a stake of 199 shares — an estimated $3K sold.

Institutional & Family Asset Management first reported a position in SBRA in Q2 2019 and held it in 14 quarters. The position peaked at $44K in Q2 2021. 327 funds tracked by Wall St. Rank hold SBRA as of Q4 2022.

  • Institutional & Family Asset Management reported no remaining Sabra Healthcare REIT position as of Q4 2022 after selling out during the quarter.
  • Institutional & Family Asset Management sold 199 Sabra Healthcare REIT shares in Q4 2022, an estimated $3K.
  • Institutional & Family Asset Management first reported a position in Sabra Healthcare REIT in Q2 2019 and held it in 14 quarters.
  • Institutional & Family Asset Management's Sabra Healthcare REIT position peaked at $44K in Q2 2021.
  • 327 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2022.

Based on Institutional & Family Asset Management's 13F filing for Q4 2022, filed 8 Feb 2023.